Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 112

1.

Pioglitazone after Ischemic Stroke or Transient Ischemic Attack.

Viscoli CM, Kernan WN, Young LH.

N Engl J Med. 2016 Aug 18;375(7):704. doi: 10.1056/NEJMc1605904. No abstract available.

2.

Pioglitazone Prevents Diabetes in Patients With Insulin Resistance and Cerebrovascular Disease.

Inzucchi SE, Viscoli CM, Young LH, Furie KL, Gorman M, Lovejoy AM, Dagogo-Jack S, Ismail-Beigi F, Korytkowski MT, Pratley RE, Schwartz GG, Kernan WN; IRIS Trial Investigators..

Diabetes Care. 2016 Oct;39(10):1684-92. doi: 10.2337/dc16-0798.

PMID:
27465265
3.

Family fun or cultural free-for-all? A critique of the 2015 National Football League Super Bowl commercials.

Basch CH, Kernan WD, Reeves R.

Health Promot Perspect. 2016 Mar 31;6(1):37-41. doi: 10.15171/hpp.2016.06.

4.

Presence of Candy and Snack Food at Checkout in Chain Stores: Results of a Pilot Study.

Basch CH, Kernan WD, Menafro A.

J Community Health. 2016 Oct;41(5):1090-3. doi: 10.1007/s10900-016-0193-7.

PMID:
27101366
5.

A Diagnostic Score for Insulin Resistance in Nondiabetic Patients with Ischemic Stroke or Transient Ischemic Attack.

Xu J, Viscoli CM, Ford GA, Gorman M, Kernan WN; IRIS Trial Investigators..

J Stroke Cerebrovasc Dis. 2016 Jul;25(7):1705-12. doi: 10.1016/j.jstrokecerebrovasdis.2016.03.043.

PMID:
27080156
6.

PRex: An Experiment to Investigate Detection of Near-field Particulate Deposition from a Simulated Underground Nuclear Weapons Test Vent.

Keillor ME, Arrigo LM, Baciak JE, Chipman V, Detwiler RS, Emer DF, Kernan WJ, Kirkham RR, MacDougall MR, Milbrath BD, Rishel JP, Seifert A, Seifert CE, Smart JE.

Health Phys. 2016 May;110(5):533-47. doi: 10.1097/HP.0000000000000506.

PMID:
27023040
7.

Using Atmospheric Dispersion Theory to Inform the Design of a Short-lived Radioactive Particle Release Experiment.

Rishel JP, Keillor ME, Arrigo LM, Baciak JE, Detwiler RS, Kernan WJ, Kirkham RR, Milbrath BD, Seifert A, Seifert CE, Smart JE.

Health Phys. 2016 May;110(5):526-32. doi: 10.1097/HP.0000000000000475.

PMID:
27023039
8.

Measuring Concentrations of Particulate 140La in the Air.

Okada CE, Kernan W, Keillor M, Kirkham R, Sorom RD, Van Etten DM.

Health Phys. 2016 May;110(5):418-26. doi: 10.1097/HP.0000000000000478.

PMID:
27023029
9.

Pioglitazone after Ischemic Stroke or Transient Ischemic Attack.

Kernan WN, Viscoli CM, Furie KL, Young LH, Inzucchi SE, Gorman M, Guarino PD, Lovejoy AM, Peduzzi PN, Conwit R, Brass LM, Schwartz GG, Adams HP Jr, Berger L, Carolei A, Clark W, Coull B, Ford GA, Kleindorfer D, O'Leary JR, Parsons MW, Ringleb P, Sen S, Spence JD, Tanne D, Wang D, Winder TR; IRIS Trial Investigators..

N Engl J Med. 2016 Apr 7;374(14):1321-31. doi: 10.1056/NEJMoa1506930.

10.

Evaluating Por Nuestra Salud: A Feasibility Study.

Marshall B, Gonzales G, Kernan W.

Health Promot Pract. 2016 Jan;17(1):137-45. doi: 10.1177/1524839915609058.

PMID:
26463170
11.

The Selling of Primary Care 2015.

Kernan WN, Elnicki DM, Hauer KE.

J Gen Intern Med. 2015 Sep;30(9):1376-80. doi: 10.1007/s11606-015-3364-9.

12.

Obesity increases stroke risk in young adults: opportunity for prevention.

Kernan WN, Dearborn JL.

Stroke. 2015 Jun;46(6):1435-6. doi: 10.1161/STROKEAHA.115.009347. No abstract available.

13.

Response to letter regarding article, "Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association".

Kernan WN, Ovbiagele B, Kittner SJ; Secondary Prevention Guideline Writing Group..

Stroke. 2015 Apr;46(4):e87-9. doi: 10.1161/STROKEAHA.115.008661. No abstract available.

14.

The case for diet: a safe and efficacious strategy for secondary stroke prevention.

Dearborn JL, Urrutia VC, Kernan WN.

Front Neurol. 2015 Feb 2;6:1. doi: 10.3389/fneur.2015.00001. Review.

15.

Pioglitazone for secondary prevention after ischemic stroke and transient ischemic attack: rationale and design of the Insulin Resistance Intervention after Stroke Trial.

Viscoli CM, Brass LM, Carolei A, Conwit R, Ford GA, Furie KL, Gorman M, Guarino PD, Inzucchi SE, Lovejoy AM, Parsons MW, Peduzzi PN, Ringleb PA, Schwartz GG, Spence JD, Tanne D, Young LH, Kernan WN; IRIS Trial investigators..

Am Heart J. 2014 Dec;168(6):823-9.e6. doi: 10.1016/j.ahj.2014.07.016.

16.

Effects of long-term blood pressure lowering and dual antiplatelet treatment on cognitive function in patients with recent lacunar stroke: a secondary analysis from the SPS3 randomised trial.

Pearce LA, McClure LA, Anderson DC, Jacova C, Sharma M, Hart RG, Benavente OR; SPS3 Investigators..

Lancet Neurol. 2014 Dec;13(12):1177-85. doi: 10.1016/S1474-4422(14)70224-8.

17.

Advancing the pharmacy practice model in a community teaching hospital by expanding student rotations.

Delgado O, Kernan WP, Knoer SJ.

Am J Health Syst Pharm. 2014 Nov 1;71(21):1871-6. doi: 10.2146/ajhp130624.

PMID:
25320137
18.

Content and timing of feedback and reflection: a multi-center qualitative study of experienced bedside teachers.

Gonzalo JD, Heist BS, Duffy BL, Dyrbye L, Fagan MJ, Ferenchick G, Harrell H, Hemmer PA, Kernan WN, Kogan JR, Rafferty C, Wong R, Elnicki MD.

BMC Med Educ. 2014 Oct 10;14:212. doi: 10.1186/1472-6920-14-212.

19.

Litigation seeking access to data from ongoing clinical trials: a threat to clinical research.

Kernan WN, Viscoli CM, Varughese MC.

JAMA Intern Med. 2014 Sep;174(9):1502-4. doi: 10.1001/jamainternmed.2014.3248.

PMID:
25047222
20.

Racial differences in the association of insulin resistance with stroke risk: the REasons for Geographic And Racial Differences in Stroke (REGARDS) study.

Howard G, Wagenknecht LE, Kernan WN, Cushman M, Thacker EL, Judd SE, Howard VJ, Kissela BM.

Stroke. 2014 Aug;45(8):2257-62. doi: 10.1161/STROKEAHA.114.005306.

Items per page

Supplemental Content

Loading ...
Support Center